A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 1380-1389

  Young, Hays W J ^a   Molina, Jose G ^a   Dimina, Dawn ^b   Zhong, Hongyan ^a,e   Jacobson, Marlene ^c   Chan, Lee Nien L ^d   Chan, Teh Sheng ^d   Lee, James J ^b   Blackburn, Michael R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e CV THERAPEUTICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 ETHYL 4 PROPYL 2 PHENYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; ADENOSINE; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE DEAMINASE; UNCLASSIFIED DRUG; MESSENGER RNA;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME DEFICIENCY; EOSINOPHIL; EOSINOPHILIA; FEMALE; IMMUNOPATHOGENESIS; INFLAMMATION; MOUSE; MUCUS; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION;

ADENOSINE DEAMINASE; ANIMALS; EOSINOPHILS; INFLAMMATION; MICE; MICE, KNOCKOUT; MUCUS; RECEPTOR, ADENOSINE A3; RESPIRATORY SYSTEM; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 3142754919     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.1380     Document Type: Article

References (49)

1. Elias, J. A., Z. Zhu, G. Chupp, and R. J. Homer. 1999. Airway remodeling in asthma. J. Clin. Invest. 104:1001.
2. Bradding, P., A. E. Redington, and S. T. Holgate. 1997. Airway wall remodelling in the pathogenesis of asthma: cytokine expression in the airways. In Airway Wall Remodelling in Asthma. A. G. Stewart, ed. CRC Press, Boca Raton, p. 29.
3. Driver, A. G., C. A. Kukoly, S. Ali, and S. J. Mustafa. 1993. Adenosine in bronchoalveolar lavage fluid in asthma. Am. Rev. Respir. Dis. 148:91.
4. Huszar, E., G. Vass, E. Vizi, Z. Csoma, E. Barat, G. Molnar Vilagos, I. Herjavecz, and I. Horvath. 2002. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur. Respir. J. 20:1393.
5. Blackburn, M. R., J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192:159.
6. Blackburn, M. R., C. G. Lee, H. W. Young, Z. Zhu, J. L. Chunn, M. J. Kang, S. K. Banerjee, and J. A. Elias. 2003. Adenosine mediates IL-13-induced inflammation 124 and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J. Clin. Invest. 112:332.
7. Fan, M., and S. J. Mustafa. 2002. Adenosine-mediated bronchoconstriction and lung inflammation in an allergic mouse model. Pulm. Pharmacol. Ther. 15:147.
8. Cushley, M. J., A. E. Tattersfield, and S. T. Holgate. 1983. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br. J. Clin. Pharmacol. 15:161.
9. Cushley, M. J., A. E. Tattersfield, and S. T. Holgate. 1984. Adenosine-induced bronchoconstriction in asthma: antagonism by inhaled theophylline. Am. Rev. Respir. Dis. 129:380.
10. Mann, J. S., M. J. Cushley, and S. T. Holgate. 1985. Adenosine-induced bronchoconstriction in asthma. Role of parasympathetic stimulation and adrenergic inhibition. Am. Rev. Respir. Dis. 132:1.
11. Oosterhoff, Y., J. W. de Jong, M. A. Jansen, G. H. Koeter, and D. S. Postma. 1993. Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am. Rev. Respir. Dis. 147:553.
12. Fredholm, B. B., I. J. AP, K. A. Jacobson, K. N. Klotz, and J. Linden. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:527.
13. Linden, J. 2001. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41:775.
14. Blackburn, M. R. 2003. Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol. Sci. 24:66.
15. Walker, B. A., M. A. Jacobson, D. A. Knight, C. A. Salvatore, T. Weir, D. Zhou, and T. R. Bai. 1997. Adenosine A3 receptor expression and function in eosinophils. Am. J. Respir. Cell Mol. Biol. 16:531.
16. Reeves, J. J., C. A. Harris, B. P. Hayes, P. R. Butchers, and M. J. Sheehan. 2000. Studies on the effects of adenosine A3 receptor stimulation on human eosinophils isolated from non-asthmatic or asthmatic donors. Inflamm. Res. 49:666.
17. Ezeamuzie, C. I., and E. Philips. 1999. Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Br. J. Pharmacol. 127:188.
18. Knight, D., X. Zheng, C. Rocchini, M. Jacobson, T. Bai, and B. Walker. 1997. Adenosine A3 receptor stimulation inhibits migration of human eosinophils. J. Leukocyte Biol. 62:465.
19. L in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood 92:778.
20. L: studies in human astroglioma cells. Biochem. Biophys. Res. Commun. 241:297.
21. Salvatore, C. A., S. L. Tilley, A. M. Latour, D. S. Fletcher, B. H. Koller, and M. A. Jacobson. 2000. Disruption of the A3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem. 275:4429.
22. Zhong, H., S. G. Shlykov, J. G. Molina, B. M. Sanborn, M. A. Jacobson, S. L. Tilley, and M. R. Blackburn. 2003. Activation of murine lung mast cells by the adenosine A3 receptor. J. Immunol. 171:338.
23. Tilley, S. L., V. A. Wagoner, C. A. Salvatore, M. A. Jacobson, and B. H. Koller. 2000. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J. Clin. Invest. 105:361.
24. Ramkumar, V., G. L. Stiles, M. A. Beaven, and H. Ali. 1993. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268:16887.
25. Kohno, Y., X. Ji, S. D. Mawhorter, M. Koshiba, and K. A. Jacobson. 1996. Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 88:3569.
26. Walker, B. A. 1996. Effects of adenosine on guinea pig pulmonary eosinophils. Inflammation 20:11.
27. Blackburn, M. R., S. K. Datta, and R. E. Kellems. 1998. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J. Biol. Chem. 273:5093.
28. Chunn, J. L., H. W. Young, S. K. Banerjee, G. N. Colasurdo, and M. R. Blackburn. 2001. Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J. Immunol. 167:4676.
29. Banerjee, S. K., H. W. Young, J. B. Volmer, and M. R. Blackburn. 2002. Gene expression profiling in inflammatory airway disease associated with elevated adenosine. Am. J. Physiol. 282:L169.
30. Blackburn, M. R., M. Wakamiya, C. T. Caskey, and R. E. Kellems. 1995. Tissue-specific rescue suggests that placental adenosine deaminase is important for fetal development in mice. J. Biol. Chem. 270:23891.
31. Blackburn, M. R., S. K. Datta, M. Wakamiya, B. S. Vartabedian, and R. E. Kellems. 1996. Metabolic and immunologic consequences of limited adenosine deaminase expression in mice. J. Biol. Chem. 271:15203.
32. Winston, J. H., G. R. Hanten, P. A. Overbeek, and R. E. Kellems. 1992. 5′ flanking sequences of the murine adenosine deaminase gene direct expression of a reporter gene to specific prenatal and postnatal tissues in transgenic mice. J. Biol. Chem. 267:13472.
33. Zhang, Y., W. J. Lamm, R. K. Albert, E. Y. Chi, W. R. Henderson, Jr., and D. B. Lewis. 1997. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am. J. Respir. Crit. Care Med. 155:661.
34. Fedorova, I. M., M. A. Jacobson, A. Basile, and K. A. Jacobson. 2003. Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration. Cell. Mol. Neurobiol. 23:431.
35. Albrecht, U., G. Eichele, J. Helms, and H. Lu. 1997. Visualization of gene expression patterns by in situ hybridization. In Molecular and Cellular Methods in Developmental Toxicology. G. Daston, ed. CRC Press, Boca Raton, p. 23.
36. Denzler, K. L., S. C. Farmer, J. R. Crosby, M. Borchers, G. Cieslewicz, K. A. Larson, S. Cormier-Regard, N. A. Lee, and J. J. Lee. 2000. Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma. J. Immunol. 165:5509.
37. Borchers, M. T., T. Ansay, R. DeSalle, B. L. Daugherty, H. Shen, M. Metzger, N. A. Lee, and J. J. Lee. 2002. In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration. J. Leukocyte Biol. 71:1033.
38. Lee, N. A., M. P. McGarry, K. A. Larson, M. A. Horton, A. B. Kristensen, and J. J. Lee. 1997. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J. Immunol. 158:1332.
39. Johnson, H. G., and M. L. McNee. 1985. Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives. Br. J. Pharmacol. 86:63.
40. Zhong, H., J. L. Chunn, J. B. Volmer, J. R. Fozard, and M. R. Blackburn. 2001. Adenosine-mediated mast cell degranulation in adenosine deaminase-deficient mice. J. Pharmacol. Exp. Ther. 298:433.
41. Lee, J. J., M. P. McGarry, S. C. Farmer, K. L. Denzler, K. A. Larson, P. E. Carrigan, I. E. Brenneise, M. A. Horton, A. Haczku, E. W. Gelfand, G. D. Leikauf, and N. A. Lee. 1997. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185:2143.
42. Wegner, C. D., R. H. Gundel, P. Reilly, N. Haynes, L. G. Letts, and R. Rothlein. 1990. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247:456.
43. Yoshikawa, M., K. Matsumoto, M. Iida, A. Akasawa, H. Moriyama, and H. Saito. 2002. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis. Int. Arch. Allergy Immunol. 128(Suppl. 1):3.
44. Corry, D. B., K. Rishi, J. Kanellis, A. Kiss, L. Z. Song Lz, J. Xu, L. Feng, Z. Werb, and F. Kheradmand. 2002. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat. Immunol. 3:347.
45. Laffargue, M., R. Calvez, P. Finan, A. Trifilieff, M. Barbier, F. Altruda, E. Hirsch, and M. P. Wymann. 2002. Phosphoinositide 3-kinase γ is an essential amplifier of mast cell function. Immunity 16:441.
46. Hawes, B. E., L. M. Luttrell, T. van Biesen, and R. J. Lefkowitz. 1996. Phosphatidylinositol 3-kinase is an early intermediate in the G βγ-mediated mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 271:12133.
47. Gao, Z., B. S. Li, Y. J. Day, and J. Linden. 2001. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol. Pharmacol. 59:76.
48. Burgel, P. R., S. C. Lazarus, D. C. Tam, I. F. Ueki, K. Atabai, M. Birch, and J. A. Nadel. 2001. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. J. Immunol. 167:5948.
49. Justice, J. P., M. T. Borchers, J. R. Crosby, E. M. Hines, H. H. Shen, S. I. Ochkur, M. P. McGarry, N. A. Lee, and J. J. Lee. 2003. Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. Am. J. Physiol. 284:L169.